as

Wednesday, 30 January 2019

IMV Announces Clinical Update for DPX-Survivac Program in Ovarian Cancer Following Positive Feedback from U.S. FDA - GlobeNewswire

IMV Announces Clinical Update for DPX-Survivac Program in Ovarian Cancer Following Positive Feedback from U.S. FDA  GlobeNewswire

DECIDE phase 2 clinical trial amendment successfully completed with multiple sites now open for enrollment. FDA provided guidance for future registration trial ...



from "updates on food" - Google News http://bit.ly/2DI8qqS

No comments:

Post a Comment